|
|
Volumn 3, Issue 12, 2013, Pages
|
|
Targeting resistance in lung cancer.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
PROTEIN TYROSINE KINASE;
DRUG ANTAGONISM;
DRUG RESISTANCE;
GENETICS;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE I AS TOPIC;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
LUNG NEOPLASMS;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 84903135828
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-ND2013-025 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|